ABLi-0901

N/A

Report date: 2025/05/27 16:01:59
NME

Base Information

Drug NameABLi-0901
Drug Alias NameABLi-0901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionABL proto-oncogene 1 inhibitors
TargetsABL proto-oncogene 1
Therapy Area/IndicationsParkinson DiseaseLewy Body DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInhibikase Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesABLi Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseLewy Body DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A